Pnc Financial Services Group, Inc. Atea Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 49 shares of AVIR stock, worth $146. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49
Previous 1,516
96.77%
Holding current value
$146
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
53.4MCall Options Held
900Put Options Held
126K-
Black Rock Inc. New York, NY9.12MShares$27.2 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$22.7 Million15.83% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$16.2 Million0.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$14.5 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.61MShares$13.7 Million1.31% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $248M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...